Retrophin Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.07 |
Market Cap |
$836.24 M |
Shares Outstanding |
41.44 M |
Public Float |
40.34 M |
Address |
3721 Valley Centre Drive San Diego California 92130 United States |
Employees | - |
Website | http://www.retrophin.com |
Updated | 07/08/2019 |
Retrophin, Inc. is a biopharmaceutical company, which engages in identifying, developing, and delivering therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA. |